March 19, 2020 / 10:14 PM / in 15 days

BRIEF-Armata Pharmaceuticals Says On March 13, Entered Into An Award Agreement With Cystic Fibrosis Foundation - SEC Filing

March 19 (Reuters) - Armata Pharmaceuticals Inc:

* ARMATA PHARMACEUTICALS SAYS ON MARCH 13, ENTERED INTO AN AWARD AGREEMENT WITH CYSTIC FIBROSIS FOUNDATION - SEC FILING

* ARMATA PHARMACEUTICALS - PURSUANT TO AGREEMENT, CO RECEIVED DEVELOPMENT AWARD OF UP TO $5.0 MILLION

* ARMATA PHARMACEUTICALS - AWARD WILL BE USED TO FUND CO'S PHASE 1B/2 CLINICAL TRIAL OF PSEUDOMONAS AERUGINOSA PHAGE CANDIDATE, AP-PA02 Source : (bit.ly/2WucJji) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below